Organizations Filed Purposes:
Research in Endocrine Biochemistry and Molecular Biophysics to develop and understand the causes of diseases and potential therapies for cure.
Guided by its motto, CURE-OSITY, the Hauptman-Woodward Medical Research Institute (HWI) creates novel strategies and technologies to promote the understanding, prevention, and treatment of many human diseases. HWI scientists conduct basic, fundamental research that will provide the foundation for effective therapeutic approaches far into the future. Often our research includes identifying proteins involved in disease which allows treatments to be more effective by targeting those proteins. Examples of current projects include breast cancer, prostate cancer, multiple myeloma, studying the effect of gravity on cells, and biological cell structure determination for nearly all disease through the use of hard X-ray free electron lasers (XFELs).
The National Science Foundation BioXFEL Science and Technology Center watched bio molecular machines at work using x-ray lasers, to better understand how life works at the molecular levels, to understand how these molecular machines support life on earth to invent, discover, develop, and provide new tools and training for the wider scientific community.
IMCA-CAT provided an outstanding support environment for macro-molecular crystallography by developing and operating an efficient, reliable, high-throughput facility at which both confidential and proprietary experiments can be readily and easily accomodated.
This multi-PI PPG examines the structure, function, mechanism, and drug targeting of the major ER chaperone Grp94.
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
| Name | Title | Hours Per Week | Total Salary |
|---|
| Lisa Keefe | VP | 0.2 | $183,007 |
| Edward Snell | President and CEO | 37.3 | $132,841 |
| Anne Kent | Chief Financial Officer | 37.3 | $122,471 |
| Jill Szczesek | Chief Operating Officer | 37.3 | $120,297 |
| Daniel Gewirth | Principal Research Scientist | 37.3 | $116,485 |
| Franca Trincia | Boardmember | 0.2 | $0 |
| Sam Russo | Boardmember | 0.2 | $0 |
| Anthony Pandolfi | Boardmember | 0.2 | $0 |
| Kunle Odunsi | Boardmember | 0.2 | $0 |
| James Obletz | Boardmember | 0.2 | $0 |
| Phil Nobel | Boardmember | 0.2 | $0 |
| Richard Mueller | Boardmember | 0.2 | $0 |
| Charles Lannon | Vice Chairperson of the Board | 0.2 | $0 |
| John Horn | Chairperson of the Board | 1 | $0 |
| Michelle Heffernan | Boardmember | 0.2 | $0 |
| Richard Hamister | Boardmember | 0.2 | $0 |
| Venu Govindaraju | Boardmember | 0.2 | $0 |
| Sash Eranki | Boardmember | 0.2 | $0 |
| Renita Distefano | Boardmember | 0.2 | $0 |
| Emily Constantine Doren | Secretary | 0.2 | $0 |
| William Constantine | Boardmember | 0.2 | $0 |
| Ej Burke | Boardmember | 0.2 | $0 |
| Jill Bond | Boardmember | 0.2 | $0 |
| Steve Bell | Boardmember | 0.2 | $0 |
| Frederick Attea | Boardmember | 0.2 | $0 |
| Christina Arthurs | Boardmember | 0.2 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/202002599349300825_public.xml